1. miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson’s Disease
   Yan-Ping Han et al, 2022, European Neurology CrossRef
2. Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease
   Hantao Zhang et al, 2022, Frontiers in Aging Neuroscience CrossRef
3. Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
   Alshimaa Magdy et al, 2022, Frontiers in Cellular Neuroscience CrossRef
4. Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1
   Mirte Scheper et al, 2023, Neuropathology and Applied Neurobiology CrossRef
5. Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators
   Hui Xu et al, 2023, Aging and disease CrossRef
6. MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
   Sushmaa Chandralekha Selvakumar et al, 2022, Frontiers in Cellular Neuroscience CrossRef
7. Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research
   Mohammad Ahmed Khan et al, 2023, Metabolic Brain Disease CrossRef
8. FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
   Nicole A. Teaney et al, 2023, Frontiers in Endocrinology CrossRef
9. Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
   Efthalia Angelopoulou et al, 2022, Brain Sciences CrossRef